Early Identification and Treatment of Prenatally Exposed Infants

< Back to All Resources

In this webinar, attendees participated in a discussion on early identification of prenatally exposed infants at birth, definition of substance exposed infants across systems, and pharmacological and non-pharmacological treatment of infants with NAS. Attendees for this webinar included medical partners, specifically pediatricians, neonatologists, and others in the medical community who work closely with substance exposed infants at birth. A portion of time is dedicated for Q&A with Dr. Burke and the SEI-IDTA sites. Dr. Sharon Burke, M.D. is the Clinical Director of the Infant Toddler Rehabilitation Program at PSE&G Children’s Specialized Hospital in New Brunswick, New Jersey where she joined in 1993. She is also clinical instructor in Pediatrics and Neonatology at Rutgers University Hospital and RWJMC. She did a pediatric internship and residency at NBIMC and Neonatal-Perinatal Fellowship at SPMC. From 1989-1993, Dr. Burke was the Clinical Director of the Neonatal Intensive Care Unit at University Hospital, Newark, NJ Dr. Burke graduated from Ross University School of Medicine in 1983. She has won several awards and honors for her work.


Related Topics

  • Behavioral Health
  • Children 0-5
  • Fetal Alcohol Spectrum Disorders (FASD)
  • Medical Care